Dual and context-dependent role of the interleukin-33/soluble suppression of tumorigenicity 2 axis in obesity and adipose tissue inflammation
Casado M., Gómez-Ambrosi J., Ramírez B., Becerril S., Rodríguez A., Valentí V.
Animal Study on Type 2 Diabetes, Chronic Inflammation, published in Mol Med (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Mol Med (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41814156
- PMCID
- PMC13094069
- DOI
- 10.1186/s10020-026-01454-z
Abstract (original English)
BACKGROUND: Obesity is increasingly recognized as a state of chronic, unresolved inflammation in which the interleukin (IL)-33/suppression of tumorigenicity 2 (ST2) axis may represent a key immunometabolic regulator. OBJECTIVE: We investigated circulating concentrations and adipose tissue expression levels of IL-33 and its soluble receptor sST2 in obesity and type 2 diabetes, and evaluated their functional effects on adipocytes and macrophages. RESULTS: Circulating IL-33 levels were significantly elevated (P < 0.01) in obesity compared with controls, being positively (P < 0.01) correlated with body mass index and HOMA-IR and negatively (P < 0.05) with HDL cholesterol. Conversely, sST2 was reduced in obesity (P < 0.05) and inversely associated with body fat percentage (P < 0.001) and fibrinogen levels (P < 0.05), suggesting enhanced IL-33 bioavailability. Visceral adipose tissue (VAT) from subjects with obesity exhibited increased IL-33 gene and protein expression levels (P < 0.01, for both). Functional analyses show that IL-33 induced (P < 0.01) the expression of adiponectin, omentin (ITLN1), and IL13 in adipocytes and attenuated (P < 0.01) LPS-driven IL1B and TNF expression. In macrophages, adipocyte-conditioned medium (ACM) from people with obesity strongly suppressed (P < 0.01) IL33 expression, while exogenous IL-33 counteracted pro-inflammatory activation, reducing LPS- and
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol